Tag: Pithampur
Lupin gets FDA nod for Allopurinol Tablets, eyeing share in $88m market
Global pharmaceutical company Lupin Limited has announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New ... Read More
Rusan Pharma launches API facility in Pithampur SEZ, Madhya Pradesh
Rusan Pharma, a global leader in healthcare and addiction treatment solutions, has recently achieved a groundbreaking milestone with the launch of its state-of-the-art Active Pharmaceutical ... Read More
Lupin gains FDA approval for generic Pitavastatin Tablets, targeting $298m market
Global pharmaceutical giant Lupin Limited announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ... Read More
Lupin gains FDA nod for generic Diflucan Tablets production
Lupin Limited, a recognized global pharmaceutical powerhouse, proudly announced its receipt of the much-anticipated approval from the US Food and Drug Administration (FDA). This authorization ... Read More
Lupin Limited secures tentative FDA nod for generic Apalutamide Tablets
In a significant stride for global pharmaceuticals, Lupin Limited has garnered tentative approval from the United States Food and Drug Administration (U.S. FDA) to introduce ... Read More
Lupin Limited gains FDA approval for generic equivalent of Esbriet Tablets
Lupin Limited announced today that it has secured approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application ... Read More
Lupin secures FDA nod for generic Bromday Ophthalmic Solution
Global pharmaceutical titan, Lupin Limited, has officially declared its success in securing the esteemed approval from the United States Food and Drug Administration (FDA). This ... Read More
Lupin gains FDA approval for generic Toprol-XL Tablets
Lupin Limited, a dominant player in the global pharmaceutical landscape, announced its triumph in obtaining the coveted approval from the United States Food and Drug ... Read More
Lupin receives FDA establishment inspection report for Pithampur Unit-2
Global pharmaceutical corporation, Lupin Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Pithampur Unit-2 facility ... Read More
Lupin clinches FDA approval for generic Spiriva HandiHaler
Indian pharma titan Lupin has announced receiving approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application for Tiotropium Bromide ... Read More